US Senator Cassidy urges delay of US vaccine discussion
June 23 (Reuters) - U.S. Senator Bill Cassidy, chair of the U.S. Senate Committee on Health, Education, Labor and Pensions called for U.S. vaccine advisers to delay a Wednesday meeting to discuss recommendations for vaccines.
"Wednesday's meeting should not proceed with a relatively small panel, and no CDC Director in place to approve the panel's recommendations," Cassidy said in a post on X, referring to the Centers for Disease Control and Prevention.
The CDC panel, known as the Advisory Committee on Immunization Practices, is scheduled to meet on June 25 and 26.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
18 minutes ago
- Daily Mail
Gloves come off in Steve Bannon's war on Fox News after lunch with Trump
Steve Bannon has taken his war on Fox News over their coverage of the Israel-Iran war to another level, suggesting the network be investigated for helping a foreign agent. The long-time Donald Trump ally, who was spotted having lunch with the president Thursday ahead of his strike on Tehran this past weekend, has been ardently against U.S. involvement and even predicted it would begin World War III. Bannon personalized it even more on Sunday, when he blamed the Murdoch family for pushing to go to war. 'People on the right are now confronting an unpleasant reality, a great unmasking: The Murdochs don't put America's interests first,' he told Semafor. 'There needs to be a thorough FARA investigation into Fox's relationship with a foreign power,' he added. The FARA is the Foreign Agents Registration Act, a law that demands public disclosure obligations on persons representing foreign interests. At the same time, Bannon dismissed the network's true influence, saying its 'audience is geriatrics - it's people 70 and over.' He also suggested they were powerless because 'it's not an activist base' being broadcast to. Bannon also made the statement on his War Room show Monday, saying: 'I think we need to see if they represent a foreign government as an agent.' 'What are they pushing on the American people? Where'd this information come from?' he asked. He clarified that while he agrees that Iran should not get a nuclear weapon, that 'there are many paths to do that' that do not involve bombing. 'None of those paths were going on the path to kinetic warfare!' has reached out to a spokesperson for Fox News for comment. Bannon, who served as Trump's chief White House strategist during his first term and continues to be an influential voice in the MAGA movement, referenced the looming attack on his 'War Room Pandemic' podcast hours before U.S. bombers carried out the strike. 'I'm just reporting what I'm hearing from pretty good sources. The party is on,' Bannon said on his podcast. 'So another big weekend in this unfolding aspect of the Third World War – and no, anyone that's telling you that the Third World War is not here, is absolutely, does not understand the development and evolution of kinetic energy,' he said. Hours later, Trump surprised the world a little before 8 p.m. ET Saturday by announcing on Truth Social that he had given the go-ahead to attack Iran. Trump used six massive 30,000-pound 'bunker buster' bombs and 30 Tomahawk missiles to destroy Fordow, Natanz and Esfahan. Trump addressed the nation, calling the strikes on a trio of Iranian nuclear sites a 'spectacular military success.' 'Tonight, I can report to the world that the strikes were a spectacular military success. Iran's key nuclear enrichment facilities have been completely and totally obliterated.' He also gave a stark warning to Tehran that more attacks would be coming if the regime didn't make peace. But his ally Bannon lunched with Trump at the White House on Thursday, and reportedly argued against the U.S. joining in Israel 's attacks on Iran. Bannon connected the dots on his 'party is on' comment, clarifying that it meant the operation was set to go. On Monday, Trump announced that Iran and Israel have agreed to a ceasefire, two weeks after they started exchanging missile strikes and two days after he bombed the Islamic Republic's nuclear labs. The president said the '12 day war' will 'end' in 24 hours, despite both nations warning of future strikes and just hours after Tehran attacked America's largest military base in the Middle East. He announced the ceasefire deal in a Truth Social post, claiming it is set to go into effect into six hours. While Israel and Iran have not confirmed if there is a deal, Trump congratulated everyone involved and said the ceasefire will begin once in-progress missions are completed. Trump broke his silence on Iran's retaliatory strikes on Monday by demanding the end of the conflict in the Middle East and taunting the Ayatollah for his 'very weak response.' The president said on Truth Social that US forces 'effectively countered' Iran's targeting of the Al Udeid Air Base in Doha, Qatar, two days after he bombed three Iranian nuclear sites. Trump said that no Americans were harmed in Iran's retaliatory strikes on Monday and declared, 'they've got it all out of their system', as he thanked Iran for giving early notice to allow the US to evacuate the base beforehand. 'Perhaps Iran can now proceed to Peace and Harmony in the Region, and I will enthusiastically encourage Israel to do the same,' he wrote, before adding in a follow-up post: 'CONGRATULATIONS WORLD, IT'S TIME FOR PEACE!' World leaders quickly condemned Iran's strikes and expressed support to Qatar, which said that it has not ruled out retaliatory strikes of its own against Iran.
Reuters
19 minutes ago
- Reuters
US, South Korea trade ministers reaffirm commitment to reaching tariff deal
SEOUL, June 24 (Reuters) - United States and South Korean trade ministers reaffirmed their commitment to reaching a deal on tariffs as early as possible during a meeting on Monday, South Korea's Ministry of Trade, Industry and Energy said on Tuesday. South Korea's top trade envoy Yeo Han-koo again sought exemptions from U.S. President Donald Trump's "reciprocal" tariffs as well as tariffs on items such as automobiles and steel, in a meeting with U.S. Secretary of Commerce Howard Lutnick and U.S. Trade Representative Jamieson Greer, the ministry said in a statement. Acting U.S. ambassador to South Korea Joseph Yun said at a seminar on Tuesday that there may be new trade talks about the Free Trade Agreement (FTA) between South Korea and the U.S., local online outlet Money Today reported.
The Independent
21 minutes ago
- The Independent
Trial finds weight loss drug taken monthly helps people lose 20% of body weight
A new trial has found that a weight loss drug taken monthly helps people lose 20 percent of their body weight. Weight loss medications such as Ozempic, Wegovy and Mounjaro have become popular and now there's a new GLP-1 drug, MariTide, being tested that could be competitive in the market. MariTide, from the drug maker Amgen, is different from the other weight loss drugs as it also has a monoclonal antibody, which allows the medication to stay in the body longer, NBC News health and medical reporter Berkeley Lovelace Jr. explained in an article published Monday. The article dives into a new trial published in The New England Journal of Medicine. Researchers analyzed nearly 600 participants, who were broken up into those with both Type 2 diabetes and obesity and those with obesity. The trial found that those with obesity alone who were treated with MariTide lost up to about 20 percent of their body weight, on average, after 52 weeks. Those with obesity alone who didn't take the MariTide only lost up to 2.6 percent of their body weight, on average. Participants who had diabetes and obesity lost up to 17 percent of their body weight, on average, while taking MariTide, according to researchers. Those with both diseases who weren't on MariTide lost up to 1.4 percent of their body weight, on average. Ozempic and similar drugs can help patients lose 15 to 20 percent of their body weight, according to Columbia University's Department of Surgery. Ozempic and other GLP-1 medications are taken weekly, but MariTide only needs to be taken monthly, making it more convenient for patients. 'It's always just easier for patients to only have to take something once per month,' Dr. Michelle Ponder, an assistant professor of medicine at Duke University School of Medicine in North Carolina, told Lovelace. Ponder, who wasn't a part of the MariTide trial, added: 'A lot of patients we see in endocrinology are diabetes patients, and so they'd be taking multiple shots of insulin per day. And so, every last shot matters, even if it's three less shots per month.' MariTide researchers said gastrointestinal issues were 'common' with the drug, but Lovelace pointed out that the drug's side effects were similar to those of other GLP-1 medications.
